Inventor · disambiguated record
Susan Wong
Also filed as: WONG SUSAN · WONG SUSAN C · WONG SUSAN CHIEN-SZU
15 granted patents·4 pending applications·159 citations·filing 2013–2023
93Inventor score
Files withBRISTOL MYERS SQUIBB CO19
Top patents by PatentIndex Score
19 records- 0198US9228016B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jan 5, 2016·85 cites·19 claims
- 0297US10501550B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Dec 10, 2019·9 cites·58 claims
- 0397US10465010B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Nov 5, 2019·9 cites·15 claims
- 0497US9745379B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Aug 29, 2017·11 cites·58 claims
- 0595US9644032B2Antibodies against OX40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2016·Granted May 9, 2017·12 cites·30 claims
- 0694US11084881B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Aug 10, 2021·3 cites·19 claims
- 0793US11213586B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR)BRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 4, 2022·5 cites·14 claims
- 0893US8945553B2Bispecific antibodies to IL-23 and IL-17A/FBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Feb 3, 2015·16 cites·12 claims
- 0992US10690674B2Anti-GITR antibodies for cancer diagnosticsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 23, 2020·5 cites·27 claims
- 1088US2024158524A1Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1184US11408889B2Anti-GITR antibodies for cancer diagnosticsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Aug 9, 2022·1 cites·20 claims
- 1283US11466092B2Antibodies against OX-40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Oct 11, 2022·1 cites·19 claims
- 1381US10683357B2Antibodies against OX40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 16, 2020·1 cites·19 claims
- 1479US2023050665A1Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1578US2023272100A1Antibodies against ox-40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1677US11802162B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Oct 31, 2023·0 cites·25 claims
- 1775US9783606B2Polynucleotides encoding IL-17/IL-23 bispecific, IL-17A/F and IL-23p19 antibodiesBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Oct 10, 2017·1 cites·71 claims
- 1871US2022175921A1Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1966US10358490B2Methods of treating inflammation with IL-17A/F and IL-23P19 bispecific antibodiesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 23, 2019·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →